|
pubmed:abstractText |
Malignant struma ovarii (MSO) are rare tumors that arise from ectopic thyroid tissue in the ovary, benign struma ovarii (BSO). Most MSO are histologically classified as papillary thyroid carcinomas (PTC). Oncogenic activation of BRAF (35% to 69%), RAS (10%), or RET (5% to 30%) is common in PTC, and the mutations correlate with tumor subtype, patient age, and clinical behavior. In this study, we explored the possible role of these genes in the development of BSO and MSO.
|
|
pubmed:affiliation |
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. jschmidt@partners.org
|
